Other Cancers Initial Safety Results of Elranatamab in R/R MM: Phase 2 MagnetisMM-3 Trial May 24, 2023
Other Cancers The Efficacy of Dabrafenib Plus Trametinib in BRAFV600E-Mutated Rare Cancers Assessed May 23, 2023
Other Cancers Cilta-Cel in Lenalidomide-Refractory MM: Study Updates and Biological Analyses May 23, 2023
Other Cancers Elotuzumab-Based Treatment for Refractory Multiple Myeloma in First Relapse Analyzed May 23, 2023
